Tag: InfuSystem Holdings

WASHINGTON – The U.S. Food and Drug Administration obtained additional information during an inspection of a Philips’ manufacturing facility that was not previously available to the agency that showed the silicone-based foam used in a singular, similar device marketed outside the U.S. failed one safety test for the release of volatile organic compounds.  Similar testing provided by Philips to the FDA on devices authorized for marketing in the U.S. had demonstrated acceptable results.  “The...

ROCHESTER HILLS, Mich. – InfuSystem reported second quarter net revenues of $24.8 million, a decrease of 4% compared to the same quarter a year ago.  Integrated Therapy Service net revenue was $16.3 million, an increase of 5% vs. prior year; DME Services net revenue was $8.5 million, a decrease of 18%; and Pain Management and Negative Pressure Wound Therapy combined net revenues increased 114%.  “2021 is proving to be a very dynamic year for InfuSystem and the health care...

WASHINGTON – Noridian Healthcare Solutions has posted FAQs for Jurisdictions A and D on the impact of the Philips recall on coverage and billing for Medicare beneficiaries, AAHomecare has reported.  Among the questions in the FAQ:  How should DME suppliers address the situation with Medicare beneficiaries who are in the first 90-days adherence metric in the PAP and RAD Local Coverage Determinations (LCDs)?  Response: During the Public Health Emergency...

ROCHESTER HILLS, Mich. – The board of directors of InfuSystem Holdings has approved a stock repurchase program allowing the company to purchase up to $20 million in stocks through June 30, 2024. “This authorization will replace the prior authorization which expired on Dec. 31, 2020, and will provide us with an additional capital allocation option to enhance shareholder value,” said Richard Dilorio, CEO. “Additionally, the stock repurchase program emphasizes the confidence...

ROCHESTER HILLS, Mich. – InfuSystem Holdings has entered into a joint agreement with Bio Compression Systems to add lymphedema therapy to its Integrated Therapy Service (ITS) platform. As part of the new relationship, InfuSystem’s solutions will include providing pneumatic compression devices with calibrated and non-calibrated gradient pressure, garments and certified technicians for proper fitting of the compression system. InfuSystem was recently designated as a Community Health Accreditation...

WASHINGTON – AAHomecare has tapped public relations firm Keybridge Communications for a media campaign to build awareness of the value of HME.  “Stepping up our strategic communications capacity is essential to our continued efforts to bring home more policy wins for HME suppliers and manufacturers,” said Tom Ryan, president and CEO. “Keybridge Communications brings a strong level of experience in developing effective messages and...

ROCHESTER HILLS, Mich. – InfuSystem, a provider of infusion pump therapy and other health care services, has acquired the operating assets of OB Healthcare Corporation, a privately held, Texas-based, biomedical services company.  The acquisition complements InfuSystem’s acquisition in February of FilAMed, a biomedical services company based in Bakersfield, Calif.   “This acquisition closely follows our purchase of FilAMed, which provides remote repair...

ROCHESTER HILLS, Mich. – InfuSystem, a provider of infusion pump therapy and other health care services, has acquired FilAMed, a biomedical services company based in Bakersfield, Calif. “The addition of FilAMed broadens and enhances our scope of biomedical services within our DME platform and provides us the opportunity to enter the acute care market,” said Richard DiIorio, CEO.  “Our customers will benefit from a broader range of services, including...

MADISON HEIGHTS, Mich. - With one of its largest competitors changing its offerings in the oncology market, InfuSystem has a chance to pick up significant market share, said CEO Rich Dilorio on a recent earnings call.“The feeling is that most of the customers they had are going to come to our site,” he said. “That should lead to material and sustained growth that's expected to show up in the second half of this year.”InfuSystem reported net revenues of $17.6 million for the...

MADISON HEIGHTS, Mich. - InfuSystem Holdings reported net revenues of $16.7 million for the third quarter of 2018, a 5% decreased compared to the same quarter in 2017. Adjusted EBITDA was $3.3 million, a 15% decrease. “We are making strong progress and gaining traction on our strategic initiatives that we believe will lead to significant oncology market share gains in 2019,” said Richard Dilorio, CEO. “This includes the introduction during the third quarter of InfuSystem Mobile,...